North America Plant-based Vaccines Market

Market Introduction

The North America plant-based vaccines market is divided into the US, Canada, and Mexico. North America is likely to capture significant share of the global market in 2021. The key factors that are driving the growth of the market are rising number of product launch along with the spur in research and development activities. However, during the forecast period the market is likely to get restrained by the factors such as challenges associated with the product approval, and the contamination and environmental risks for manufacturing plant-based vaccines.

North America is one of the most important regions for the adoption and growth of new technologies due to flattering government policies to boost innovation, the presence of a huge industrial base, and high purchasing power of consumers, mainly in major countries such as the US and Canada. Hence, any impact on the growth of industries affects the region's economic growth negatively. The US is the world’s worst-affected country due to the COVID-19 outbreak. The US is an eminent plant-based vaccines market as the major market players are located in the US. The factory and business shutdowns across the US, Canada, and Mexico negatively impacted various industries in 2020. On the other side, the pandemic has offered vital growth opportunities for the players operating in the plant-based vaccines market due to rising numbers of COVID-19 patients. For instance, several businesses are pursuing research and development for the creation of COVID-19 vaccines based on plants. For instance, in June 2021, iBio, a biotech innovator and biologics contract manufacturing organization, announced that preclinical studies of IBIO-202, its subunit vaccine candidate that targets the nucleocapsid protein (“N protein”) of SARS-CoV-2, demonstrated a robust, antigen-specific, and memory T-cell response. The development of plant-based vaccine fuels the growth of the market.   

Market Overview and Dynamics

The plant-based vaccines market in North America is expected to grow from US$ 498.66 million in 2021 to US$ 1,181.06 million by 2028; it is estimated to grow at a CAGR of 13.1% from 2021 to 2028. Infectious disorders or diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungus, and they can be transmitted from one person to another either directly or indirectly. These diseases can be divided into three categories – diseases that cause high levels of mortality, diseases that inflict a large load of disability on populations, and diseases that—due to their rapid and unexpected spread—can have serious consequences. Many of the major health factors and infectious disease causes are beyond the health sector's direct control. Sanitation and water supply, environmental and climate change, education, agriculture, trade, tourism, transportation, industrial development, and housing are among the other sectors engaged.   

Key Market Segments

North America plant-based vaccines market is segmented into vaccine type, source, application, and country. Based on vaccine type, the North America plant-based vaccines market is segmented into bacterial vaccines, viral vaccines, parasite vaccines, plant-derived virus-like particles, and others. The bacterial vaccines segment held the largest share of the market in 2021. Based on source, the North America plant-based vaccines market is segmented into tobacco plant, maize, potato, and others. The tobacco plant segment held the largest share of the market in 2021. Based on application, the North America plant-based vaccines market is segmented into influenza, zika virus, Ebola virus, poultry disease, COVID-19, and others. The influenza segment held the largest share of the market in 2021. Based on country, the North America plant-based vaccines market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the plant-based vaccines market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are British American Tobacco p.l.c.; Creative Biolabs, Inc.; Fraunhofer; iBio, Inc.; Leaf Expression Systems Ltd.; LenioBio; Lumen Bioscience, Inc.; Medicago, Inc.; and ZYUS Life Sciences Inc.        

Reasons to buy report

• To understand the North America plant-based vaccines market landscape and identify market segments that are most likely to guarantee a strong return.
• Stay ahead of the race by comprehending the ever-changing competitive landscape for North America plant-based vaccines market.
• Efficiently plan M&A and partnership deals in North America plant-based vaccines market by identifying market segments with the most promising probable sales.
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America plant-based vaccines market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

North America

Plant-based Vaccines Market

Segmentation

North America Plant-based Vaccines Market -

By Vaccine Type

• Bacterial Vaccines
• Viral Vaccines
• Parasite Vaccines
• Plant-Derived Virus-Like Particles
• Others

North America Plant-based Vaccines Market - By

Source

• Tobacco Plant
• Maize
• Potato
• Others

North America Plant-based Vaccines Market - By Application

• Influenza
• Zika Virus
• Ebola Virus
• COVID-19
• Poultry Disease
• Others

North America Plant-based Vaccines Market - By Country

• US
• Canada
• Mexico

North America Plant-based Vaccines Market - Company Profiles

• British American Tobacco p.l.c.
• Creative Biolabs, Inc.     
• Fraunhofer
• iBio, Inc.
• Leaf Expression Systems Ltd.
• LenioBio
• Lumen Bioscience, Inc.
• Medicago, Inc.
• ZYUS Life Sciences Inc.

North America Plant-based Vaccines Strategic Insights

Strategic insights for the North America Plant-based Vaccines provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Plant-based Vaccines Report Scope

North America Plant-based Vaccines Regional Insights

The geographic scope of the North America Plant-based Vaccines refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.